Cerebrospinal fluid biomarkers of symptomatic neurosyphilis in people with HIV compared with uninfected individuals

Abstract

Abstract We evaluated the diagnostic clinical performance characteristics (DCPC) of cerebrospinal fluid (CSF) total protein (TP), white blood cell count (WBC), and lactate (LA) with different cutoff points as adjunct biomarkers of confirmed or presumptive symptomatic neurosyphilis (NS) and the impact of HIV infection. From 5,640 participants who underwent lumbar punctures, 236 participants were included, and classified as either people with HIV (PWH) or people without HIV (PWoH) according to the CDC criteria for confirmed NS (n=42), presumptive NS (n=74), systemic syphilis (SS) (n=38), serological diagnosis of syphilis (n=18), PWH without SS and NS (n=10), and negative control (n=72). In PWoH, for presumptive NS, the combination of CSF TP >45 mg/dL and/or WBC >5.0 cells/mm3 is valuable for screening, whereas in PWH, it is not recommended for either screening or case-finding NS. In PWoH, the value of CSF TP >45 mg/dL is adequate for both screening and confirmation of presumptive NS, subject to prevalence. For WBC count >20 cell/mm3, the positive predictive value (PPV) of the test is almost perfect, suggesting a confirmatory test. In PWH, CSF TP is an inadequate marker of NS. The WBC count, with cutoffs of >10 or >20 cells/mm3, was moderately applicable for screening. As conclusions: CSF WBC count and TP showed distinct DCPC in confirmed or presumptive NS, being better in the former. However, these biomarkers could be included for presumptive NS diagnosis. Additionally, the DCPC of these biomarkers for the diagnosis of NS is greatly affected by HIV co-infection.